Systematic discovery of drug action mechanisms by an integrated chemical genomics approach: identification of functional disparities between azacytidine and decitabine-Reference-Cited by-同舟云学术

Systematic discovery of drug action mechanisms by an integrated chemical genomics approach: identification of functional disparities between azacytidine and decitabine

Published:2016-03-29 Issue:19 Volume:7 Page:27363-27378
ISSN:1949-2553
Container-title:Oncotarget
language:en
Short-container-title:Oncotarget

Author:

Hsieh Yao-Yu¹²,Huang Tsui-Chin¹³,Lo Hsiang-Ling¹³,Jhan Jyun-Yan¹³,Chen Shui-Tein¹⁴,Yang Pei-Ming¹³

Affiliation:

1. PhD Program for Cancer Biology and Drug Discovery, College of Medical Science and Technology, Taipei Medical University and Academia Sinica, Taipei, Taiwan

2. Division of Hematology and Oncology, Shuang Ho Hospital, Taipei Medical University, Taipei, Taiwan

3. Graduate Institute of Cancer Biology and Drug Discovery, College of Medical Science and Technology, Taipei Medical University, Taipei, Taiwan

4. Institute of Biological Chemistry, Academia Sinica, Taipei, Taiwan

Publisher

Impact Journals, LLC

Subject

Oncology

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. 5-Azacytidine Inhibits the Activation of Senescence Program and Promotes Cytotoxic Autophagy during Trdmt1-Mediated Oxidative Stress Response in Insulinoma β-TC-6 Cells;Cells;2022-04-04

2. General Strategies for Rational Design and Discovery of Multitarget Drugs;Polypharmacology;2022

3. Optimizing DNA hypomethylating therapy in acute myeloid leukemia and myelodysplastic syndromes;BioEssays;2021-08-31

4. Autophagy Promoted Neural Differentiation of Human Placenta-derived Mesenchymal Stem Cells;In Vivo;2021

5. Drug candidate identification based on gene expression of treated cells using tensor decomposition-based unsupervised feature extraction for large-scale data;BMC Bioinformatics;2019-02